Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9DC22

Entry ID Method Resolution Chain Position Source
AF-Q9DC22-F1 Predicted AlphaFoldDB

58 variants for Q9DC22

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388511434 102 F>L No EVA
rs3388511035 134 Q>H No EVA
rs864264600 179 K>N No EVA
rs3388512844 199 I>N No EVA
rs3388509575 201 P>S No EVA
rs3388513490 203 V>L No EVA
rs3388512808 217 R>Q No EVA
rs3390923521 260 C>* No EVA
rs3390937104 260 C>Y No EVA
rs3388508996 327 S>N No EVA
rs3410870026 336 S>N No EVA
rs3388509892 351 R>S No EVA
rs38212627 379 D>E No EVA
rs254202550 405 A>V No EVA
rs3390882949 421 Q>K No EVA
rs3390926345 421 Q>L No EVA
rs37348469 431 R>H No EVA
rs237699428 438 C>S No EVA
rs216269293 445 Q>H No EVA
rs3388515888 456 H>L No EVA
rs3388513607 498 W>C No EVA
rs3388515900 504 S>T No EVA
rs3388514441 512 C>R No EVA
rs237283061 525 S>N No EVA
rs3388510069 549 P>S No EVA
rs3388510087 575 G>* No EVA
rs3388509944 575 G>V No EVA
rs219179067 577 K>R No EVA
rs233069187 582 Q>H No EVA
rs217608728 588 L>V No EVA
rs259572363 591 E>D No EVA
rs235518455 593 T>A No EVA
rs3388512089 593 T>I No EVA
rs3388513253 594 L>M No EVA
rs251582252 596 E>D No EVA
rs3388513891 597 T>A No EVA
rs225979263 605 A>T No EVA
rs3388513285 607 T>I No EVA
rs578921928 608 E>D No EVA
rs3388509547 609 S>I No EVA
rs227201993 616 T>A No EVA
rs1134846917 620 L>R No EVA
rs3388514111 628 E>* No EVA
rs264417328 633 E>D No EVA
rs250057831 639 T>A No EVA
rs3388513570 639 T>I No EVA
rs264517429 641 A>T No EVA
rs238036344 642 N>K No EVA
rs219213689 645 L>R No EVA
rs3388509515 659 D>Y No EVA
rs3388512821 701 E>* No EVA
rs3388509530 724 L>I No EVA
rs3390928719 773 L>P No EVA
rs3388509940 816 K>E No EVA
rs3388513291 828 M>I No EVA
rs3388514504 856 D>G No EVA
rs3388513185 874 D>E No EVA
rs3388514058 876 E>K No EVA

No associated diseases with Q9DC22

8 regional properties for Q9DC22

Type Name Position InterPro Accession
binding_site IQ motif, EF-hand binding site 692 - 719 IPR000048
repeat WD40 repeat 40 - 79 IPR001680-1
repeat WD40 repeat 82 - 124 IPR001680-2
repeat WD40 repeat 130 - 170 IPR001680-3
repeat WD40 repeat 184 - 220 IPR001680-4
repeat WD40 repeat 238 - 281 IPR001680-5
repeat WD40 repeat 722 - 763 IPR001680-6
repeat WD40 repeat 766 - 805 IPR001680-7

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
Cul4-RING E3 ubiquitin ligase complex A ubiquitin ligase complex in which a cullin from the Cul4 family and a RING domain protein form the catalytic core; substrate specificity is conferred by an adaptor protein.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
focal adhesion A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

1 GO annotations of molecular function

Name Definition
nuclear receptor coactivator activity A transcription coactivator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound nuclear receptor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator.

2 GO annotations of biological process

Name Definition
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
protein ubiquitination The process in which one or more ubiquitin groups are added to a protein.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P0C7V8 DCAF8L2 DDB1- and CUL4-associated factor 8-like protein 2 Homo sapiens (Human) PR
Q5TAQ9 DCAF8 DDB1- and CUL4-associated factor 8 Homo sapiens (Human) PR
A6NGE4 DCAF8L1 DDB1- and CUL4-associated factor 8-like protein 1 Homo sapiens (Human) PR
Q58WW2 DCAF6 DDB1- and CUL4-associated factor 6 Homo sapiens (Human) PR
10 20 30 40 50 60
MARSGSCPHL LWDVRKRSLG LEDPSRLRSR YLGRREFIQR LKLEATLNVH DGCVNTICWN
70 80 90 100 110 120
DTGEYILSGS DDTKLVISNP YSRKVLTTIR SGHRANIFSA KFLPCTDDKQ IVSCSGDGVI
130 140 150 160 170 180
FYTNIEQDAE TNRQCQFTCH YGTTYEIMTV PNDPYTFLSC GEDGTVRWFD TRIKTSCTKE
190 200 210 220 230 240
DCKDDILINC RRAATSVAIC PPVPYYLAVG CSDSSVRIYD RRMLGTRATG NYAGRGTTGM
250 260 270 280 290 300
VARFIPSHLS NKSCRVTSLC YSEDGQEILV SYSSDYIYLF DPKDDTAREL KTPSAEERRE
310 320 330 340 350 360
ELRQPPVKRL RLRGDWSDTG PRARPESERE RDGEQSPNVS LMQRMSDMLS RWFEEASEVA
370 380 390 400 410 420
QSNRGRGRPR PRGGTNQPDV STLPTVPSSP NLEVCETAMD VDMPAALLQP STSSTDPVQA
430 440 450 460 470 480
QAATAAIESP RSSSLLSCPD SEPRQSVEAS GHHAHHQSDN SNERLSPKPG TGEPVLSLHY
490 500 510 520 530 540
STEGTTTSTI KLNFTDEWSS TASSSRGNGS HCKSEGQEEC LVPPSSVQPP EGDSETRAPE
550 560 570 580 590 600
ELSEKGTLPE NLTQNQIDTA QLDNFPAEPL DSNSGEKNNP SQDSPCGLPE EGTLSETDRE
610 620 630 640 650 660
TCEQASTESA TRHASTKPEL PSQTEAIEQA STESATRHTS ANPELPSQTE AIAPLAHEDP
670 680 690 700 710 720
SARDSALQDT DDSDDDPVLI PGARYRTGPG DRRSAVARIQ EFFRRRKERK EMEELDTLNI
730 740 750 760 770 780
RRPLVKMVYK GHRNSRTMIK EANFWGANFV MSGSDCGHIF IWDRHTAEHL MLLEADNHVV
790 800 810 820 830 840
NCLQPHPFDP ILASSGIDYD IKIWSPLEES RIFNRKLADE VITRNELMLE ETRNTITVPA
850 860 870
SFMLRMLASL NHIRADRLEG DRSEGSGQEN ENEDEE